Robert J Gould

Director

Robert J Gould (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales, 1 filed past the two-business-day deadline), most often in Fulcrum Therapeutics, Inc. (FULC). The largest single filing was $178K of FULC (15,000 sh × $11.87, as filed), executed Jan 2.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells · 1 late

Median delay

–

execution → disclosure

Volume, ttmiDollar value disclosed in the trailing twelve months

$667K

shares × price, as filed

Last traded

Feb 2

Filed Feb 4

Median ADV $9.2M across their filed names

Open performance→

Volume by month

Buys $0 Sells $667K

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

FULC

Fulcrum Therapeutics, Inc. FULC · 0 buys · 4 sells 4 filings

Recent filings

FULCSALE Fulcrum Therapeutics, Inc. View filing → $161K
15,000 sh × $10.72
Exec Feb 2
Filed Feb 4 · 5:30 PM ET FULCSALE Fulcrum Therapeutics, Inc. View filing → $178K
15,000 sh × $11.87
Exec Jan 2
Filed Jan 6 · 5:30 PM ET FULCSALE Fulcrum Therapeutics, Inc. View filing → $163K
15,000 sh × $10.87
Exec Jan 2
Filed Feb 4 · 5:30 PM ET † FULCSALE Fulcrum Therapeutics, Inc. View filing → $165K
15,000 sh × $11.03
Exec Nov 19 2025
Filed Nov 21 2025 · 5:30 PM ET